Inhibition of androgen receptor (AR) signalling is the primary method of treatment for metastatic PCa, and androgen deprivation therapy (ADT) in combination with anti-androgen drugs or docetaxel chemotherapy significantly prolongs life expectancy in PCa patients. This evidence concerns the gene AR and posterior cortical atrophy.